- Drugs
- Thursday, 21 Sep 2023
US Pharmacy Management System Market is expected to reach US$ 53,139.59 million by 2030
Solution Held Largest Share of Component Segment in the US Pharmacy Management System Market
According to our new research study on "US Pharmacy Management System Market Forecasts (2020 - 2030), Country Share, Trends, and Growth Opportunity Analysis – by Component, Deployment, Size of Pharmacies, and End User," the market was valued at US$ 21,017.59 million in 2022 and is expected to reach US$ 53,139.59 million by 2030. It is estimated to register a CAGR of 12.29% during 2022–2030.
A pharmacy management software is any system used in a pharmacy that helps to automate the workflow. It includes making drug orders and controlling the inventory, reviewing physician orders and preparing medications, handling insurance and billing, identifying incompatibilities, providing counseling, and others while following the legal protocols and compliances.
To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00030067
Based on components, the pharmacy management system market is segmented into solutions and services. The solutions segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030. The solutions segment is further divided into EMR/HER, inventory management, purchase order management, supply chain management, regulatory and compliance information, clinical pharmacy management, and others. Pharmacy management systems are software solutions implemented in pharmacies to organize, manage, and store medication-related data. Some advanced management solutions can offer clinical decision support that helps to alert the pharmacists to perform clinical interventions and further demand education for a patient’s prescription.
Based on deployment, the pharmacy management system market is bifurcated into cloud-based and on-premises. The cloud-based segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030. Cloud-based deployment offers a safer and more standardized information system to manage patient data. Cloud-based pharmacy management systems can be connected to computers via the internet and web browser, which enables access to the data anytime and anywhere, on different devices.
McKesson Corp., Becton Dickinson and Co., Allscripts Healthcare LLC., Epicor Software Corp, Swisslog Healthcare AG, Omnicell IncInc., CPS Solutions LLC, RedSail Technologies LLC, Micro Merchant Systems Inc, and Oracle Corp are among the leading companies operating in the US pharmacy management system market.
The report segments the US pharmacy management system market as follows:
The US pharmacy management system market is segmented into componet, deployment, size of pharmacies, and end user. By componet, the US pharmacy management system market is bifurcated into solutions and services. The US pharmacy management system market is bifurcated by deployment into cloud-based and on-premise. Based on the size of pharmacies, the US pharmacy management system is bifurcated into segmented into small- and medium-sized pharmacies, and large pharmacies. Based on end user, the US pharmacy management system market is segmented into in-patient pharmacies and outpatient pharmacies.
Contact Us
Contact Us: The Insight Partners
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com
Related Industry Updates
Generic Drugs Market Effect Factors Analysis 2027 – Apotex, Pfizer, Endo Pharmaceuticals, Fresenius Kabi AG, Lupin Pharmaceuticals and Cipla
Mar 15, 2021
Pharmaceutical Contract Sales Organizations Market is expected to reach US$ 15,820.86 million by 2030
Oct 11, 2023
Patient's genetic profile will now offer Personalize medicine
Sep 27, 2019
TOWA PHARMACEUTICAL CO., LTD. reaches an agreement with ESTEVE to acquire ESTEVE's generic division, Pensa Investments
Dec 24, 2019
Infectious Disease Therapeutics Market is expected to reach US$ 1,67,883.93 million by 2030
Jan 25, 2024
FDA Approves Harmony Biosciences' Sleep Disorder Drug
Sep 04, 2019
Non-Gelatin Empty Capsules Market is expected to reach US$ 4.64 billion by 2030
Feb 14, 2024